Basic Study
Copyright ©The Author(s) 2016.
World J Hepatol. Apr 8, 2016; 8(10): 499-508
Published online Apr 8, 2016. doi: 10.4254/wjh.v8.i10.499
Figure 2
Figure 2 Tyrosine predicts 6-mo liver transplant-free survival in patients with end-stage liver disease. AUC: Area under receiver operating characteristics curve; OLT: Orthotopic liver transplantation; MELD: Model for end-stage liver disease.